Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vulvar Neoplasms × Sentinel Lymph Node Biopsy × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Sentinel Lymph Node 1 Neoplasm Micrometastasis 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometrial Neoplasms 1 Eccrine Porocarcinoma 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1

Interventions

Surveys and Questionnaires 3 Surgical Procedures, Operative 2 trastuzumab deruxtecan 1 Watchful Waiting 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 RNA 1 Psychiatric Rehabilitation 1 Observation 1 Multimodal Imaging 1 Indocyanine Green 1 Immunohistochemistry 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Drug Therapy 1 DNA 1 Circulating Tumor DNA 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04147780 2023-11-01

SNEX

Karolinska University Hospital

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡